Policy | October 12, 2025
AstraZeneca to lower cost of medicines for American patients
AstraZeneca to invest $50bn in manufacturing and R&D to support domestic sourcing
AstraZeneca to invest $50bn in manufacturing and R&D to support domestic sourcing
The three-day expo will feature an expansive exhibition showcasing MSMEs, startups, research institutions, future innovation pavilions, state showcases, and government initiatives
Enhance strategies to drive sustainability, global Reach and digital transformation for a trillion-dollar future
The company has received Export Performance Award - API & Intermediaries Gold Star for the year 2021-22
Drug formulations and biologics make impressive gains
Subscribe To Our Newsletter & Stay Updated
